Advanced search

62 Results

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Neurocrine Biosciences Announces CEO Succession Plan	05-28	PR
Neurocrine Biosciences Announces Appointment of Christine A. Poon to Board of Directors	23-07-11	PR
NEUROCRINE BIOSCIENCES INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	23-05-19	AQ
DARE BIOSCIENCE, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-06-24	AQ
REGULUS THERAPEUTICS INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	22-06-13	AQ
Neurocrine Biosciences : 2021 Annual Report*	22-06-03	PU
NEUROCRINE BIOSCIENCES INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	22-05-23	AQ
Dare Bioscience : 2021 Proxy Statement	21-07-08	PU
REGULUS THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	21-06-16	AQ
FATE THERAPEUTICS INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	21-06-07	AQ
Transcript : Fate Therapeutics, Inc. - Shareholder/Analyst Call	21-06-02
NEUROCRINE BIOSCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)	21-05-21	AQ
Neurocrine Biosciences : Announces Appointment of Johanna Mercier to Board of Directors	21-04-19	AQ
Neurocrine Biosciences : Announces Appointment of Johanna Mercier to Board of Directors	21-04-16	PR
Dare Bioscience : Current Report (SEC Filing - 8-K)	21-02-16	PU
Daré Bioscience Reports Second Quarter 2020 Financial Results and Provides Company Update	20-08-12	GL
REGULUS THERAPEUTICS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	20-06-19	AQ
NEUROCRINE BIOSCIENCES INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	20-05-21	AQ
Fate Therapeutics Announces Changes to its Board of Directors	20-05-05	GL
Neurocrine Biosciences : Announces Appointment of Shalini Sharp to Board of Directors	20-02-03	PR
REGULUS THERAPEUTICS INC. : Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	19-12-26	AQ
Regulus Therapeutics Inc. announced that it has received $42.736888 million in funding from a group of investors	19-12-25	CI
Neurocrine Biosciences : Announces Appointment of Leslie V. Norwalk to Board of Directors	19-09-11	PR
Daré Bioscience, Inc. Announces Board Changes	19-07-15	CI
Daré Bioscience Announces Appointment of Dr. William H. Rastetter as Chairman of the Board of Directors	19-07-15	GL
Daré Bioscience Announces Appointment of Dr. William H. Rastetter as Chairman of the Board of Directors	19-07-15	CI
ViaSat : CONNECT to Honor Three Distinguished Innovators at Annual Awards	18-10-22	PU
Transcript : Daré Bioscience, Inc. - Shareholder/Analyst Call	18-07-10
Neurocrine Biosciences : Chief Executive Officer of Neurocrine Biosciences, Kevin Gorman, Ph.D., Named EY Entrepreneur Of The Year® 2018 San Diego	18-06-08	PR
Daré Bioscience, Inc. Announces Board Changes	17-07-20	CI
Cerulean Pharma : Urges Stockholders to Vote for Proposals at July 19, 2017 Special Stockholder Meeting	17-06-27	BU
Cerulean Pharma : and Daré Announce Awards for Daré CEO	17-05-08	BU
Transcript : Illumina Inc., Q4 2015 Earnings Call, Feb 02, 2016	16-02-02
Illumina Inc. Announces Board Changes	16-02-01	CI
Illumina : Forms New Company to Enable Early Cancer Detection via Blood-Based Screening	16-01-10	BU
Grail announced that it has received $100 million in funding from Arch Venture Partners, L.P., Illumina Inc., Sutter Hill Ventures, Bezos Expeditions, LLC, and other investors.	16-01-09	CI
Distinguished Life Sciences Leaders to be Honored at CLSA's 2015 Pantheon DiNA Awards Ceremony	15-11-09	GL
Neurocrine Biosciences : Announces the Appointment of George J. Morrow to its Board of Directors	15-09-30	PR
Biogen : Neurocrine Biosciences Announces the Appointment of Dr. Alfred W. Sandrock to its Board of Directors	15-09-03	PR
Corporate Directors Forum : Honors Six San Diego Executives with 2015 Director of The Year Awards	15-07-15	PR
Transcript : Illumina Inc. - Shareholder/Analyst Call	15-05-27
Capital One Financial : Project Update, Awards, Appointment, Product Launch, and Sponsorship - Research Reports on D.R. Horton, Mallinckrodt, Illumina, Ventas and Capital One Financial	14-09-29	PR
Fate Therapeutics, Inc. Announces Board Changes	14-06-11	CI
Regulus Therapeutics Inc. Elects Bruce L.A. Carter, Mark G. Foletta, William Rastetter and Douglas Williams as Directors	13-06-12	CI
Regulus Therapeutics Inc : Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors	13-04-01	PR
Regulus Appoints William H. Rastetter to its Board	13-04-01	CI
Cerulean Pharma Inc. announced that it has received $28 million from a group of investors.	12-11-29	CI
Fate Therapeutics, Inc. Appoints Christian Weyer as President and Chief Executive Officer	12-10-15	CI
Illumina, Inc. : Illumina Announces Preliminary Voting Results for 2012 Annual Meeting of Stockholders	12-04-18	BU
Illumina, Inc. : Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote for the Election of All Illumina Nominees Using Management’s WHITE Proxy Card	12-04-10	PU

No results for this search

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer